Cargando…
Risk of dialysis in patients receiving intravitreal anti–vascular endothelial growth factor treatment: a population-based cohort study
We utilized the Longitudinal Health Insurance Database which was stemmed from the Taiwan's National Health Insurance Research Database to conduct a retrospective cohort study investigating the risk of becoming dialysis dependent after receiving intravitreal anti-vascular endothelial growth fact...
Autores principales: | Yang, Shun-Fa, Su, Yu-Chen, Lim, Chen-Chee, Huang, Jing-Yang, Hsu, Sheng-Min, Wu, Li-Wha, Chang, Yi-Sheng, Hung, Jia-Horung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271293/ https://www.ncbi.nlm.nih.gov/pubmed/35724264 http://dx.doi.org/10.18632/aging.204133 |
Ejemplares similares
-
Risk of Glaucoma in Patients Receiving Hemodialysis and Peritoneal Dialysis: A Nationwide Population-Based Cohort Study
por: Lim, Chen-Chee, et al.
Publicado: (2020) -
Intraocular Pressure Changes in Non-Glaucomatous Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Agents
por: Kiddee, Weerawat, et al.
Publicado: (2015) -
Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
por: Lin, Tzu-Yi, et al.
Publicado: (2023) -
Profile of patients receiving intravitreal anti-vascular endothelial growth factor injections during COVID-19-related lockdown
por: Sindal, Manavi D, et al.
Publicado: (2021) -
Association between Obstetric Complications and Intravitreal Anti-Vascular Endothelial Growth Factor Agents or Intravitreal Corticosteroids
por: Ben Ghezala, Inès, et al.
Publicado: (2022)